{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_tazarotene",
          "name": "Tazarotene"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tazarotene",
          "type": "Drug",
          "label": "Tazarotene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_cytokine_inhibition",
          "type": "Target",
          "label": "Cytokine Inhibition",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_immunomodulation_pathway",
          "type": "Pathway",
          "label": "Immunomodulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_skin_inflammation",
          "type": "Pathway",
          "label": "Skin Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "ph_reduction_inflam",
          "type": "Phenotype",
          "label": "Reduction in Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "ph_skin_clearance",
          "type": "Phenotype",
          "label": "Skin Clearance",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_infliximab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "针对细胞因子的直接抑制作用"
        },
        {
          "source": "t_cytokine_inhibition",
          "target": "p_immunomodulation_pathway",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与免疫调节通路的关系"
        },
        {
          "source": "p_immunomodulation_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通过免疫调节影响该疾病"
        },
        {
          "source": "drug_adalimumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "属于抗细胞因子类药物"
        },
        {
          "source": "drug_apremilast",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过抑制炎症细胞因子起效"
        },
        {
          "source": "drug_acitretin",
          "target": "p_skin_inflammation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "可能通过减轻皮肤炎症作用"
        },
        {
          "source": "p_skin_inflammation",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接影响该皮肤病"
        },
        {
          "source": "drug_methotrexate",
          "target": "p_skin_inflammation",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "常用抗风湿药物，影响皮肤炎症"
        },
        {
          "source": "drug_cyclosporine",
          "target": "p_immunomodulation_pathway",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过免疫抑制作用产生效果"
        },
        {
          "source": "drug_etanercept",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "另一种抗细胞因子药物"
        },
        {
          "source": "drug_vedolizumab",
          "target": "p_immunomodulation_pathway",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "调整免疫系统以应对炎症"
        },
        {
          "source": "drug_ustekinumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "针对特定细胞因子的抗体治疗"
        },
        {
          "source": "drug_secukinumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "以细胞因子为靶点的治疗机制"
        },
        {
          "source": "drug_brodalumab",
          "target": "t_cytokine_inhibition",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "发挥抑制作用"
        },
        {
          "source": "drug_tazarotene",
          "target": "p_skin_inflammation",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "具有皮肤有效性"
        },
        {
          "source": "p_skin_inflammation",
          "target": "ph_skin_clearance",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "改善皮肤状况"
        },
        {
          "source": "p_immunomodulation_pathway",
          "target": "ph_reduction_inflam",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "减少炎症反应的支持证据"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过免疫调节及减少炎症影响大疱性脓疱性银屑病",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物可有效到达相关靶点并产生作用（常识判断）"
    ],
    "uncertainties": [
      "某些药物的具体作用机制仍需进一步研究"
    ],
    "next_focus_for_pi": [
      "是否考虑补充特定药物的具体临床数据？"
    ]
  }
}